KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Other Operating Expenses (2018 - 2025)

Historic Other Operating Expenses for Xenon Pharmaceuticals (XENE) over the last 4 years, with Q3 2025 value amounting to -$6.7 million.

  • Xenon Pharmaceuticals' Other Operating Expenses fell 4735.57% to -$6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.8 million, marking a year-over-year decrease of 5747.27%. This contributed to the annual value of -$20.7 million for FY2024, which is 4369.09% down from last year.
  • Xenon Pharmaceuticals' Other Operating Expenses amounted to -$6.7 million in Q3 2025, which was down 4735.57% from -$6.0 million recorded in Q2 2025.
  • Over the past 5 years, Xenon Pharmaceuticals' Other Operating Expenses peaked at -$4.6 million during Q3 2024, and registered a low of -$6.7 million during Q3 2025.